In Vivo CRO Market Size To Reach $7.93 Billion By 2030
In vivo CRO Industry Overview The global in vivo CRO market size was estimated at USD 4.59 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030. The increasing burden of cancer patients, growing in vivo pharmacology studies, and the emerging number of pharma and biotechnology companies focusing on researching and developing novel therapeutics are expected to drive market growth during the forecast period. In addition, in vivo CROs are specifically backed by the rising number of CROs, research and development activities, and preclinical studies, which have led to a rise in market growth. Furthermore, growing investments across in vivo gene-modified cell therapies are expected to boost market growth. For instance, in November 2023, the CCR researchers announced the development of a new technology to support T-cell therapies to function better against solid tumors utilizing mice models with ped...